RU2018130117A - Композиции, полезные в предупреждении и/или лечении воспаления и боли - Google Patents

Композиции, полезные в предупреждении и/или лечении воспаления и боли Download PDF

Info

Publication number
RU2018130117A
RU2018130117A RU2018130117A RU2018130117A RU2018130117A RU 2018130117 A RU2018130117 A RU 2018130117A RU 2018130117 A RU2018130117 A RU 2018130117A RU 2018130117 A RU2018130117 A RU 2018130117A RU 2018130117 A RU2018130117 A RU 2018130117A
Authority
RU
Russia
Prior art keywords
extract
zanthoxylum
spp
lipophilic
curcumin
Prior art date
Application number
RU2018130117A
Other languages
English (en)
Other versions
RU2018130117A3 (ru
RU2752320C2 (ru
Inventor
Эцио БОМБАРДЕЛЛИ
Original Assignee
Индена С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Индена С.П.А. filed Critical Индена С.П.А.
Publication of RU2018130117A publication Critical patent/RU2018130117A/ru
Publication of RU2018130117A3 publication Critical patent/RU2018130117A3/ru
Application granted granted Critical
Publication of RU2752320C2 publication Critical patent/RU2752320C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/758Zanthoxylum, e.g. pricklyash
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544Phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/548Phosphates or phosphonates, e.g. bone-seeking
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Claims (29)

1. Композиции, содержащие:
а) экстракт Curcuma longa, куркумин или комплекс куркумина с фосфолипидами;
б) липофильный экстракт Zingiber officinale; и
в) липофильный экстракт, полученный из растений, содержащих изобутиламиды полиненасыщенных жирных кислот, выбранный из группы, состоящей из экстракта Echinacea spp., экстракта Zanthoxylum spp. и экстракта Acmella oleracea (Spilanthes oleracea).
2. Композиции по п. 1, содержащие:
а) комплекс куркумина с фосфолипидами;
б) липофильный экстракт Zingiber officinale; и
в) липофильный экстракт Echinacea spp., Zanthoxylum spp. или Acmella oleracea (Spilanthes oleracea), предпочтительно экстракт Zanthoxylum spp., более предпочтительно экстракт Zanthoxylum bungeanum.
3. Композиции по п. 1 или 2, содержащие в стандартной дозе для перорального введения:
а) комплекс куркумина с фосфолипидами в количестве от 50 до 1000 мг,
б) липофильный экстракт Zingiber officinale в количестве от 10 до 80 мг,
в) липофильный экстракт Zanthoxylum spp. в количестве от 1 до 50 мг или, альтернативно, липофильный экстракт Echinacea spp. или Acmella oleracea (Spilanthes oleracea) в количестве от 5 до 50 мг.
4. Композиции по п. 3, содержащие в стандартной дозе для перорального введения:
а) 250 мг комплекса куркумина с фосфолипидами;
б) 50 мг липофильного экстракта Zingiber officinale; и
в) 10 мг липофильного экстракта Zanthoxylum spp.
5. Композиции по п. 1 или 2 для местного введения, содержащие:
а) комплекс куркумина с фосфолипидами в количестве от 0,1 до 0,5% масс/масс,
б) липофильный экстракт Zingiber officinale в количестве 0,5% масс/масс, и
в) липофильный экстракт Zanthoxylum spp. в количестве от 0,1 до 1% масс/масс, предпочтительно 0,5% масс/масс.
6. Композиции по п. 5, содержащие:
а) 0,05% масс/масс, комплекса куркумина с фосфолипидами,
б) 0,5% масс/масс, липофильного экстракта Zingiber officinale,
в) 0,5% масс/масс, липофильного экстракта Zanthoxylum spp.
7. Композиции по любому из пп. 1-3, где экстракт Echinacea spp. получен из Echinacea angustifolia или purpurea.
8. Композиции по любому из пп. 1-6, где экстракт Zanthoxylum spp. получен из Zanthoxylum bungeanum, Zanthoxylum piperitum или Zanthoxylum armatum.
9. Композиции по любому из пп. 1-8, где экстракт Zingiber officinale имеет содержание гингеролов и шогаолов в диапазоне от 20 до 30% масс/масс, предпочтительно 25% масс/масс.
10. Композиции по любому из пп. 1-9 для использования в предупреждении и/или лечении воспаления и боли.
11. Композиции для использования по п. 10, где воспаление и боль являются костно-суставными.
RU2018130117A 2016-02-24 2017-02-20 Композиции, полезные в предупреждении и/или лечении воспаления и боли RU2752320C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102016000019244 2016-02-24
ITUB2016A001030A ITUB20161030A1 (it) 2016-02-24 2016-02-24 Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore
PCT/EP2017/053787 WO2017144411A1 (en) 2016-02-24 2017-02-20 Compositions useful in the prevention and/or treatment of inflammation and pain

Publications (3)

Publication Number Publication Date
RU2018130117A true RU2018130117A (ru) 2020-03-25
RU2018130117A3 RU2018130117A3 (ru) 2020-05-12
RU2752320C2 RU2752320C2 (ru) 2021-07-26

Family

ID=56027067

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018130117A RU2752320C2 (ru) 2016-02-24 2017-02-20 Композиции, полезные в предупреждении и/или лечении воспаления и боли

Country Status (20)

Country Link
US (1) US11534472B2 (ru)
EP (1) EP3419641B1 (ru)
JP (1) JP7111617B2 (ru)
KR (1) KR20180113538A (ru)
CN (1) CN108697751B (ru)
AU (1) AU2017222166B2 (ru)
BR (1) BR112018016965B1 (ru)
CA (1) CA3015119A1 (ru)
DK (1) DK3419641T3 (ru)
ES (1) ES2913094T3 (ru)
HU (1) HUE058915T2 (ru)
IL (1) IL261240B (ru)
IT (1) ITUB20161030A1 (ru)
MX (1) MX2018010060A (ru)
PL (1) PL3419641T3 (ru)
PT (1) PT3419641T (ru)
RU (1) RU2752320C2 (ru)
SG (1) SG11201807032PA (ru)
SI (1) SI3419641T1 (ru)
WO (1) WO2017144411A1 (ru)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1031315A (zh) 1988-09-13 1989-03-01 孙守连 调味汁制法
DK0464298T3 (da) 1990-07-05 1995-11-13 Indena Spa Echinacea-ekstrakter, fremgangsmåde til fremstilling deraf og formuleringer, der indeholder dem
ITMI981542A1 (it) 1998-07-07 2000-01-07 Indena Spa Estratti di zanthoxylum bungeanum e loro formulazioni farmaceutiche e cosmetiche
CN101249256A (zh) 2008-04-11 2008-08-27 李庭华 一种治疗重风湿性关节炎药剂的制配方法
IT1401141B1 (it) * 2010-07-26 2013-07-12 Indena Spa Formulazioni contenenti estratti di echinacea angustifolia e di zingiber officinale utili nella riduzione dell'infiammazione e del dolore periferico
US9088471B1 (en) * 2014-02-19 2015-07-21 Qualcomm Incorporated Quadrature combining and adjusting
SG11201606831PA (en) * 2014-02-20 2016-09-29 Indena Spa Compositions containing extracts of curcuma longa and echinacea angustifolia which are useful to reduce peripheral inflammation and pain
CN105012901A (zh) * 2014-12-02 2015-11-04 陈方标 颈腰透骨消痛液搽剂
CN104758451A (zh) * 2015-04-28 2015-07-08 童长虹 一种治疗痛风的中药组合物
CN104921053A (zh) * 2015-07-06 2015-09-23 天宁香料(江苏)有限公司 一种鸡肉味调味香精的制备方法
ITUA20164757A1 (it) * 2016-06-29 2017-12-29 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento dell’infiammazione e del dolore osteoarticolare e del danno cartilagineo

Also Published As

Publication number Publication date
US11534472B2 (en) 2022-12-27
AU2017222166B2 (en) 2023-11-09
BR112018016965B1 (pt) 2022-10-25
KR20180113538A (ko) 2018-10-16
RU2018130117A3 (ru) 2020-05-12
BR112018016965A2 (pt) 2019-01-08
CN108697751B (zh) 2022-01-21
EP3419641A1 (en) 2019-01-02
ITUB20161030A1 (it) 2017-08-24
EP3419641B1 (en) 2022-04-06
JP2019506421A (ja) 2019-03-07
PT3419641T (pt) 2022-05-13
WO2017144411A1 (en) 2017-08-31
CA3015119A1 (en) 2017-08-31
AU2017222166A1 (en) 2018-09-06
JP7111617B2 (ja) 2022-08-02
HUE058915T2 (hu) 2022-09-28
IL261240B (en) 2022-05-01
RU2752320C2 (ru) 2021-07-26
DK3419641T3 (da) 2022-04-19
CN108697751A (zh) 2018-10-23
PL3419641T3 (pl) 2022-06-27
SI3419641T1 (sl) 2022-06-30
SG11201807032PA (en) 2018-09-27
US20210205388A1 (en) 2021-07-08
IL261240A (en) 2018-10-31
MX2018010060A (es) 2019-01-21
ES2913094T3 (es) 2022-05-31

Similar Documents

Publication Publication Date Title
RU2019100779A (ru) Композиции, полезные для предупреждения и/или лечения костно-суставного воспаления и боли и повреждения хряща
Hakim et al. Gelam honey and ginger potentiate the anti cancer effect of 5-FU against HCT 116 colorectal cancer cells
CO6270234A2 (es) Composiciones bucales que contiene extractos botanicos
CY1119968T1 (el) Συνθεσεις καινοτομων καλλυντικων και/ή φαρμακευτικων προϊοντων και χρησεις αυτων
HRP20130977T1 (hr) Pripravci koji sadrže lipofilne ekstrakte zingiber officinale i echinacea angustifolia za prevenciju i lijeäśenje gastroezofagealne refluksne bolesti
RU2007138393A (ru) Лекарственное средство из экстрактов растений в качестве ингибитора липазы
RU2018111036A (ru) Композиции, содержащие экстракт эхинацеи и производные соединения линолевой кислоты
RU2018136872A (ru) Композиции, содержащие 15-oh эпк, и способы их применения
MX2016010722A (es) Composiciones que contienen extractos de curcuma longa y echinacea angustifolia que son utiles para reducir la inflamacion periferica y el dolor.
MY147378A (en) Herba formulation for wound healing
WO2014106860A3 (en) Synergistic dietary supplement for enhancing physical performance
EA201891337A2 (ru) Фармацевтическая композиция от нейропатической боли
SI2906233T1 (en) Pharmaceutical forms for the treatment and prevention of obesity
HRP20211160T1 (hr) Kompozicije koje sadrže geraniol i suhi đumbir za uporabu u liječenju sindroma iritabilnog crijeva
RU2015154451A (ru) Композиция для повышения качества спермы у субъекта мужского пола
HRP20160774T1 (hr) Pripravci za liječenje umora povezanog s karcinomom
RU2018130117A (ru) Композиции, полезные в предупреждении и/или лечении воспаления и боли
WO2012123962A3 (en) A novel herbal composition for the treatment of wound healing, a regenerative medicine
RU2016117460A (ru) Средство, обладающее гиполипидемическим, гепатозащитным и антиоксидантным действием
MA41102A (fr) Compositions contenant de la curcumine à biodisponibilité améliorée
MX2019007078A (es) Procedimiento para la preparacion de composiciones en polvo.
JP2020511488A5 (ru)
RU2022104737A (ru) Композиции для лечения атопического дерматита
Abid et al. Pharmacological evaluation of Atremisia annua for Antinociceptive Activity in rats
Bhandari et al. Quantitative Determination of Antioxidant Potential of Five Selected Essential Oils of Nepalese Origin